Since the vaccine only covers some high-risk types of HPV, cervical cancer screening is recommended even after vaccination.[1][11] In the US, the recommendation is for women to receive routine Pap smears beginning at age 21. Additional vaccine candidate research is occurring for next generation products to extend protection against additional HPV types.